NO20003956L - Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten - Google Patents

Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten

Info

Publication number
NO20003956L
NO20003956L NO20003956A NO20003956A NO20003956L NO 20003956 L NO20003956 L NO 20003956L NO 20003956 A NO20003956 A NO 20003956A NO 20003956 A NO20003956 A NO 20003956A NO 20003956 L NO20003956 L NO 20003956L
Authority
NO
Norway
Prior art keywords
loop
vector containing
adenovirus vector
peptide epitope
heterologous peptide
Prior art date
Application number
NO20003956A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003956D0 (no
Inventor
David T Curiel
Victor N Krasnykh
Igor Dmitriev
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Publication of NO20003956D0 publication Critical patent/NO20003956D0/no
Publication of NO20003956L publication Critical patent/NO20003956L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO20003956A 1998-02-06 2000-08-04 Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten NO20003956L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7394798P 1998-02-06 1998-02-06
US9980198P 1998-09-10 1998-09-10
PCT/US1999/002549 WO1999039734A1 (en) 1998-02-06 1999-02-05 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob

Publications (2)

Publication Number Publication Date
NO20003956D0 NO20003956D0 (no) 2000-08-04
NO20003956L true NO20003956L (no) 2000-10-05

Family

ID=26755086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003956A NO20003956L (no) 1998-02-06 2000-08-04 Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten

Country Status (11)

Country Link
US (1) US7297542B2 (https=)
EP (1) EP1053013A4 (https=)
JP (1) JP2002507391A (https=)
KR (1) KR20010034487A (https=)
CN (1) CN1304316A (https=)
AU (1) AU744252B2 (https=)
BR (1) BR9908613A (https=)
CA (1) CA2327545A1 (https=)
IL (1) IL137681A0 (https=)
NO (1) NO20003956L (https=)
WO (1) WO1999039734A1 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395875B1 (en) * 1999-01-25 2002-05-28 Brookhaven Science Associates Llc Recombinant soluble adenovirus receptor
US7157266B2 (en) * 1999-01-25 2007-01-02 Brookhaven Science Associates Llc Structure of adenovirus bound to cellular receptor car
US7560527B1 (en) 1999-11-25 2009-07-14 Transgene S.A. Modified adenovirus fibre and uses
CN1230441C (zh) 2000-04-12 2005-12-07 安盛药业有限公司 结合整联蛋白的肽衍生物
JP3635462B2 (ja) 2000-05-31 2005-04-06 国立医薬品食品衛生研究所長 アデノウイルスベクター
JP2003534805A (ja) 2000-05-31 2003-11-25 ユニバーシティ オブ サスカチュワン 変化した親和性を有する改変ウシアデノウイルス
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
WO2003006491A2 (en) 2001-07-10 2003-01-23 Amersham Health As Peptide-based compounds for targeting intergin receptors
EP1446479B1 (en) 2001-09-29 2012-08-15 Chae-Ok Yun Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus
US20060228334A1 (en) * 2002-07-10 2006-10-12 Manuel Rosa-Calatrava Modified adenoviral fiber with ablated to cellular receptors
US20060281090A1 (en) * 2003-05-01 2006-12-14 University Of Washington Uw Tech Transfer- Invention Licensing Capsid-modified adenovirus vectors and methods of using the same
US7611868B2 (en) 2003-05-14 2009-11-03 Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Recombinant modified adenovirus fiber protein
US20070104732A1 (en) * 2003-10-24 2007-05-10 Bernard Massie Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
CA2552262C (en) 2004-02-02 2016-04-19 The University Of British Columbia Scodaphoresis and methods and apparatus for moving and concentrating particles
US8529744B2 (en) 2004-02-02 2013-09-10 Boreal Genomics Corp. Enrichment of nucleic acid targets
US10337054B2 (en) 2004-02-02 2019-07-02 Quantum-Si Incorporated Enrichment of nucleic acid targets
US7473418B2 (en) 2004-03-25 2009-01-06 Cell Genesys, Inc. Pan cancer oncolytic vectors and methods of use thereof
DE102004021584A1 (de) * 2004-05-03 2005-12-01 Stefan Kochanek Modifizierte virale Vektorpartikel
US7776322B2 (en) 2004-08-16 2010-08-17 Stefan Kochanek Modified viral vector particles
CA2496294A1 (en) * 2005-02-07 2006-08-07 The University Of British Columbia Apparatus and methods for concentrating and separating particles such as molecules
JP6092497B2 (ja) 2006-03-30 2017-03-08 ユニバーシティー オブ カリフォルニア 抗ｃｔｌａ−４抗体の限局性分泌のための方法および組成物
US7919079B2 (en) 2006-03-31 2011-04-05 Biosante Pharmaceuticals, Inc. Cancer immunotherapy compositions and methods of use
WO2008140474A1 (en) * 2006-10-26 2008-11-20 Johns Hopkins University Recombinant adenovirus vaccines
EP2238434A4 (en) 2008-02-01 2011-06-22 Univ British Columbia METHOD AND DEVICE FOR PARTICLE INTRODUCTION AND RECOVERY
WO2009137211A2 (en) * 2008-05-04 2009-11-12 University Of Maryland Biotechnology Institute Off. Of Research Admin./ Tech. Dev. Fibrous assemblies for antibody presentation, and multiplexed antigenic analysis using same
US20110256055A1 (en) 2008-12-23 2011-10-20 Ge Healthcare Limited Application of 99mtc peptide-based compound as a bone marrow imaging agent
US8877028B2 (en) 2009-04-21 2014-11-04 The University Of British Columbia System and methods for detection of particles
ES2385251B1 (es) 2009-05-06 2013-05-06 Fundació Privada Institut D'investigació Biomèdica De Bellvitge Adenovirus oncolíticos para el tratamiento del cáncer.
US9458473B2 (en) * 2010-06-29 2016-10-04 The Johns Hopkins University Compositions and methods for retargeting virus constructs
CA2742327A1 (en) 2011-05-20 2012-11-20 The University Of British Columiba Systems and methods for enhanced scoda
WO2013090806A2 (en) * 2011-12-15 2013-06-20 Washington University Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection
WO2013104994A2 (en) 2012-01-13 2013-07-18 The University Of British Columbia Multiple arm apparatus and methods for separation of particles
CA3215250A1 (en) * 2012-03-13 2013-09-19 Salk Institute For Biological Studies Selective cell targeting using adenovirus and chemical dimers
WO2013166444A2 (en) 2012-05-04 2013-11-07 Boreal Genomics Corp. Biomarker analysis using scodaphoresis
AU2014236207B2 (en) 2013-03-14 2019-05-23 Salk Institute For Biological Studies Oncolytic adenovirus compositions
US9340835B2 (en) 2013-03-15 2016-05-17 Boreal Genomics Corp. Method for separating homoduplexed and heteroduplexed nucleic acids
CN104634978A (zh) * 2013-11-13 2015-05-20 长春百克生物科技股份公司 一种分型检测腺病毒中和抗体的方法以及用于分型检测腺病毒中和抗体的试剂盒
WO2016025469A1 (en) * 2014-08-11 2016-02-18 The Board Of Regents Of The University Of Texas System Prevention of muscular dystrophy by crispr/cas9-mediated gene editing
KR20250081944A (ko) 2014-09-24 2025-06-05 솔크 인스티튜트 포 바이올로지칼 스터디즈 종양 살상 바이러스 및 이의 사용방법
US11130986B2 (en) 2015-05-20 2021-09-28 Quantum-Si Incorporated Method for isolating target nucleic acid using heteroduplex binding proteins
EP4155411A1 (en) 2016-02-23 2023-03-29 Salk Institute for Biological Studies Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
WO2017147265A1 (en) 2016-02-23 2017-08-31 Salk Institute For Biological Studies High throughput assay for measuring adenovirus replication kinetics
EP3532082A4 (en) 2016-12-12 2020-08-26 Salk Institute for Biological Studies SYNTHETIC ADENOVIRUS TUMOR TARGETING AND THEIR USES
EP3565578A1 (en) 2016-12-21 2019-11-13 Memgen LLC Armed replication-competent oncolytic adenoviruses
MX2020000244A (es) 2017-06-27 2020-09-28 Regeneron Pharma Vectores virales recombinantes con tropismo modificado y usos de estos para la introduccion dirigida de material genetico a celulas humanas.
MX2020010499A (es) 2018-04-09 2020-10-28 Salk Inst For Biological Studi Composiciones de adenovirus oncoliticas con propiedades aumentadas de replicacion.
EP3927833A4 (en) 2019-02-21 2022-11-30 Unleash Immuno Oncolytics, Inc. ONCOLYTIC ADENOVIRAL VECTOR AND METHODS OF USE
AU2020372908A1 (en) 2019-10-29 2022-06-02 Quantum-Si Incorporated Peristaltic pumping of fluids and associated methods, systems, and devices

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223084D0 (en) * 1992-11-04 1992-12-16 Imp Cancer Res Tech Compounds to target cells
US5846782A (en) 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US5770442A (en) * 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
EP0866721A4 (en) * 1995-12-08 2003-06-04 Univ Alabama Birmingham Res Fo TARGET ADENOVIRAL VECTORS
AU767904B2 (en) * 1999-05-12 2003-11-27 Uab Research Foundation, The Infectivity-enhanced conditionally-replicative adenovirus and uses thereof

Also Published As

Publication number Publication date
CN1304316A (zh) 2001-07-18
IL137681A0 (en) 2001-10-31
KR20010034487A (ko) 2001-04-25
US7297542B2 (en) 2007-11-20
AU744252B2 (en) 2002-02-21
JP2002507391A (ja) 2002-03-12
EP1053013A1 (en) 2000-11-22
NO20003956D0 (no) 2000-08-04
AU2659599A (en) 1999-08-23
BR9908613A (pt) 2000-10-31
WO1999039734A1 (en) 1999-08-12
EP1053013A4 (en) 2004-12-22
CA2327545A1 (en) 1999-08-12
US20020081280A1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
NO20003956L (no) Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten
DE69422632D1 (de) Antigen enthaltende nicht-ionische Tensid Vesikel
DE69833503D1 (de) Mechanismus der unterbrechung von bestimmungsortredirektion ausführt
FI930836A0 (fi) Topiska preparat som innehaoller cyklosporin
FI924982L (fi) Frystorkat preparat som innehaoller monoklonal motkropp
DE69835976D1 (de) Polarisationsunabhängiger optischer Phasenmodulator
EP0676188A3 (en) Stable single-phase self-foaming cleanser.
NO20006056D0 (no) Optiske fiberbånd som inneholder strålingsherdede innkapslingsmaterialer
DK12893D0 (da) Fremgangsmaade til fremstilling af normal saavel som ultrafin cement
NO990877L (no) Stabilt, eksternt preparat inneholdende aspirin
DK0813876T3 (da) Cyclosporinholdigt præparat i form af en blød kapsel
FI925246A0 (fi) Fluorerade aldoketendimerer och deras anvaendning som kombinerade olje och vatten resistenta lim foer cellulosa material
DK1109450T3 (da) Mikrokapselpræparater
DE69521163D1 (de) Optischer Halbleitermodulator
DE69521515D1 (de) Quantenkryptographie
FI970727A0 (fi) Foerfarande och anordning foer torkning av objekt som innehaoller vatten
DE69817897D1 (de) Phasenregelkreis
DE19881428D2 (de) Lustiges Gyros-Spielzeug
ZA200003905B (en) Adenovirus Vector containing A Heterologous Peptide Epitope in the HI Loop of the Fiber Knob.
NO984307D0 (no) Anvendelsen av spesielle tilberedninger som avskummere
FI963615A0 (fi) Peptidit, jotka estävät pepsiinin vapautumisen
NO305192B1 (no) Ryggsekkforankring
FI971519A0 (fi) Sits som foerblir ren
TW329983U (en) Wafer having protection loop
FI973964A0 (fi) Foerfarande och anordning foer alstring av traeflis som anvaends i massafabrikationsprosess

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application